Brain Imaging
Research Study
Research study involving state-of-the-art brain imaging at Stony Brook University Medical Center
Stony Brook, NY
Compensation Provided
Chronic Depression
Free Outpatient Treatment
18 - 65 Years Old
Fast Facts
About this research study:
Treating depression using an FDA-approved* anti-inflammatory (nonsteroidal anti- inflammatory drug, NSAID)
The Department of Psychiatry at Stony Brook University is one of the region's premier providers of psychiatric services and a national leader in neuroimaging research. The study involves Positron Emission Tomography (PET) and Magnetic Resonance Imaging (MRI) imaging of the brain. PET and MRI brain imaging is performed before and after 8 weeks of NSAID treatment. This medication is FDA approved as an anti-inflammatory and may be effective to treat depression, especially if other treatments have failed. Your participation in this research study may help further our understanding of depression and other psychiatric illnesses.

*Please note: This medication is currently FDA approved as an anti-inflammatory, not as an antidepressant medication.
Additional Information